India to United States: Syringe Export Trade Route

The India to United States Syringe corridor is one of India's established pharmaceutical export routes, with 581 shipments documented worth a combined $66.1M USD. The route is dominated by GLAND PHARMA LTD, which alone accounts for roughly 71% of all export value, reflecting the consolidated nature of India's syringe manufacturing sector.

Across 16 active suppliers, the average shipment value stands at $113.7K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 70% of all shipments, consistent with syringe's non-urgent bulk-order profile.

Shipment activity peaks during October–December, with an average transit time of 18 days port-to-port. The route has recorded an annual growth rate of 26.5%, placing it at rank #20 among India's top syringe export destinations globally.

On the import side, key buyers of Indian syringe in United States include FRESENIUS KABI USA, LLC, FRESENIUS KABI USA LLC, EVERSANA and 24 others. FRESENIUS KABI USA, LLC is the single largest importer with 341 shipments valued at $35.6M USD.

India's syringe exports to United States are driven primarily by a handful of large-scale manufacturers. GLAND PHARMA LTD with 437 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 16 active exporters signals a competitive but concentrated market — buyers in United States benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — GLAND PHARMA LTD, GLAND PHARMA LIMITED, EUGIA PHARMA SPECIALITIES LIMITED — together account for 99% of total trade value on this route. The average shipment value of $113.7K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as low molecular weight heparin enoxaparinsodium injection usp 40mg in 0 4ml prefilled syringe and (low molecular weight heparin) enoxaparin sodium injection usp, 40mg in 0.4ml pre-filled syringes, suggesting that buyers in United States tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, FRESENIUS KABI USA, LLC is the largest importer with 341 shipments worth $35.6M USD — representing 54% of all syringe imports from India on this route. A total of 27 buyers are active on this corridor.